Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Livestream 2021
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • CCC Excellence Lecture
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    European journal of cancer (Oxford, England : 1990). 2021 Sep 8. pii: S0959-8049(21)00444-5. doi: 10.1016/j.ejca.2021.06.049
    Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts.
    Haggenmüller S1,  Maron RC2,  Hekler A3,  Utikal JS4,  Barata C5,  Barnhill RL6,  Beltraminelli H7,  Berking C8,  Betz-Stablein B9,  Blum A10,  Braun SA11,  Carr R12,  Combalia M13,  Fernandez-Figueras MT14,  Ferrara G15,  Fraitag S16,  French LE17,  Gellrich FF18,  Ghoreschi K19,  Goebeler M20,  Guitera P21,  Haenssle HA22,  Haferkamp S23,  Heinzerling L24,  Heppt MV25,  Hilke FJ26,  Hobelsberger S27,  Krahl D28,  Kutzner H29,  Lallas A30,  Liopyris K31,  Llamas-Velasco M32,  Malvehy J33,  Meier F34,  Müller CSL35,  Navarini AA36,  Navarrete-Dechent C37,  Perasole A38,  Poch G39,  Podlipnik S40,  Requena L41,  Rotemberg VM42,  Saggini A43,  Sangueza OP44,  Santonja C45,  Schadendorf D46,  Schilling B47,  Schlaak M48,  Schlager JG49,  Sergon M50,  Sondermann W51,  Soyer HP52,  Starz H53,  Stolz W54,  Vale E55,  Weyers W56,  Zink A57,  Krieghoff-Henning E58,  Kather JN59,  von Kalle C60,  Lipka DB61,  Fröhling S62,  Hauschild A63,  Kittler H64,  Brinker TJ65
    Author information
    1Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
    2Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
    3Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
    4Department of Dermatology, Heidelberg University, Mannheim, Germany; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    5Institute for Systems and Robotics (ISR/IST), Instituto Superior Técnico, University of Lisbon, Portugal.
    6Departments of Pathology and Translational Research, Institut Curie, Paris, France.
    7Department of Dermatology, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland.
    8Department of Dermatology, University Hospital Erlangen, Erlangen, Germany.
    9The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia.
    10Public, Private and Teaching Practice of Dermatology, Konstanz, Germany.
    11Department of Dermatology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany; Department of Dermatology, University Hospital Münster, Germany.
    12Department of Pathology, Warwick Hospital, Warwick, UK.
    13Department of Dermatology, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Ciber de Enfermedades Raras ISCIII, Barcelona, Spain.
    14Hospital Universitari General de Catalunya, Grupo Quironsalud, Universitat Internacional de Catalunya, Sant Cugat Del Vallés, Barcelona, Spain.
    15Anatomic Pathology Unit, Macerata General Hospital, Macerata, Italy.
    16Department of Pathology, University Paris Descartes, Necker-Enfants Malades Hospital, Assistance Publique Hospitals of Paris, Paris, France.
    17Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany; Dr. Philip Frost, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
    18Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
    19Charité - Universitätsmedizin Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.
    20Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
    21Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia; Melanoma Institute Australia, And the University of Sydney, Australia.
    22Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.
    23Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
    24Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
    25Department of Dermatology, University Hospital Erlangen, Erlangen, Germany.
    26Charité - Universitätsmedizin Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.
    27Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
    28Dres. Krahl Dermatopathology, Heidelberg, Germany.
    29Dermatopathology Friedrichshafen, Friedrichshafen, Germany.
    30First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University, Thessaloniki, Greece.
    31Memorial Sloan Kettering Cancer Center, New York, NY, USA.
    32Department of Dermatology, University Hospital La Princesa, Madrid, Spain.
    33Department of Dermatology, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Ciber de Enfermedades Raras ISCIII, Barcelona, Spain.
    34Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
    35Institute for Histology, Cytology and Molecular Diagnostic, Trier, Germany.
    36Department of Dermatology, University Hospital of Basel, Switzerland.
    37Department of Dermatology, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
    38Anatomic and Cytopathology, Az. ULSS 8 Berica, Regione Veneto, Ospedale San Bortolo, Vicenza, Italy.
    39Charité - Universitätsmedizin Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.
    40Department of Dermatology, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Ciber de Enfermedades Raras ISCIII, Barcelona, Spain.
    41Dermatology Department, Hospital Fundación Jiménez Díaz, Madrid, Spain.
    42Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
    43Dermatopathology Friedrichshafen, Friedrichshafen, Germany.
    44Dermatopathology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
    45Pathology Department, Fundación Jiménez Díaz, Madrid, Spain.
    46German Cancer Consortium (DKTK), Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
    47Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
    48Charité - Universitätsmedizin Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.
    49Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
    50Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.
    51Department of Dermatology, Venereology and Allergology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
    52The University of Queensland Diamantina Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia.
    53Dermpath München, Munich, Germany.
    54Department of Dermatology, Allergology and Environmental Medicine II, Hospital Thalkirchner Street, Munich, Germany.
    55Department of Dermatology and Dermatopathology, Hospital da Luz, Lisbon, Portugal.
    56Center for Dermatopathology, Freiburg, Germany.
    57Department of Dermatology and Allergy, Faculty of Medicine, Technical University of Munich, 80802, Munich, Germany.
    58Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
    59Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
    60Department of Clinical-Translational Sciences, Charité University Medicine and Berlin Institute of Health (BIH), Berlin, Germany.
    61German Cancer Consortium (DKTK), Heidelberg, Germany; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
    62German Cancer Consortium (DKTK), Heidelberg, Germany; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
    63Department of Dermatology, University Hospital of Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
    64ViDIR Group, Department of Dermatology, Medical University of Vienna, Vienna, Austria.
    65Digital Biomarkers for Oncology Group, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany. Electronic address: titus.brinker@dkfz.de.
    Abstract

    BACKGROUND: Multiple studies have compared the performance of artificial intelligence (AI)-based models for automated skin cancer classification to human experts, thus setting the cornerstone for a successful translation of AI-based tools into clinicopathological practice.

    OBJECTIVE: The objective of the study was to systematically analyse the current state of research on reader studies involving melanoma and to assess their potential clinical relevance by evaluating three main aspects: test set characteristics (holdout/out-of-distribution data set, composition), test setting (experimental/clinical, inclusion of metadata) and representativeness of participating clinicians.

    METHODS: PubMed, Medline and ScienceDirect were screened for peer-reviewed studies published between 2017 and 2021 and dealing with AI-based skin cancer classification involving melanoma. The search terms skin cancer classification, deep learning, convolutional neural network (CNN), melanoma (detection), digital biomarkers, histopathology and whole slide imaging were combined. Based on the search results, only studies that considered direct comparison of AI results with clinicians and had a diagnostic classification as their main objective were included.

    RESULTS: A total of 19 reader studies fulfilled the inclusion criteria. Of these, 11 CNN-based approaches addressed the classification of dermoscopic images; 6 concentrated on the classification of clinical images, whereas 2 dermatopathological studies utilised digitised histopathological whole slide images.

    CONCLUSIONS: All 19 included studies demonstrated superior or at least equivalent performance of CNN-based classifiers compared with clinicians. However, almost all studies were conducted in highly artificial settings based exclusively on single images of the suspicious lesions. Moreover, test sets mainly consisted of holdout images and did not represent the full range of patient populations and melanoma subtypes encountered in clinical practice.


    Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

    KEYWORDS: Artificial intelligence, Convolutional neural network(s), Deep learning, Dermatology, Digital biomarkers, Machine learning, Malignant melanoma, Skin cancer classification

    Publikations ID: 34509059
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt